Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
20.50    -0.50 (-2.33%)
Bid:
20.00
Ask:
21.00
Spread: 1.00 (5.00%)
Market Cap: £18.83m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

Ukraine Order

9 Nov 2022 07:00

RNS Number : 7454F
Inspiration Healthcare Group PLC
09 November 2022
Β 

Β 

Β 

Β 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Β 

Β 

Ukraine Order

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company,Β is pleased to announce that it has received an order worth over Euro 300k* for the supply of its CosyTherm2 patient warming system to a charity which is acquiring medical products for hospitals in Ukraine. It is anticipated that the order will be completed and delivered before the end of this financial year.

The lightweight and compact CosyTherm2Β warming system is designed for use with pre-term infants to maintain normothermia in delivery suites, maternity wards, neonatal intensive care departments and special care baby units.

Neil Campbell, Chief Executive Officer, commented:Β "We are delighted to supply these units to the Ukraine in these difficult times and pleased to be playing a small part in improving outcomes in what is a very difficult situation."

Β 

*Approximately Β£260K GBP

Β 

Enquiries:

Β 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Jon Ballard, Chief Financial Officer

Tel: +44 (0)330 175 0000Β 

Cadogan PR

Alex Walters

alex.walters@cadoganpr.com

Tel: 07771 713608

Β 

About Inspiration Healthcare Group

Β 

www.inspirationhealthcaregroup.plc.uk

Β 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

Β 

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries. Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.

Β 

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products. The Group also acts as a distributor for 3rdΒ party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS

Β 

The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

Β 

Further information on Inspiration Healthcare Group plc can be seen at www.inspirationhealthcaregroup.plc.ukΒ 

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word β€œReach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAUWAWRUKUARAA
Date   Source Headline
29th Oct 20213:07 pmRNSDirector/PDMR Shareholding
25th Oct 202110:15 amRNSReplacement: Director/PDMR Shareholding
22nd Oct 20214:35 pmRNSDirector/PDMR Shareholding
20th Oct 20215:02 pmRNSDirector/PDMR Shareholding
5th Oct 20217:00 amRNSInterim Results
4th Oct 20217:00 amRNSTR1 Notification
24th Sep 20217:00 amRNSNotice of Results, Mello and AIM Awards
11th Aug 20217:00 amRNSTrading Update
27th Jul 202110:13 amRNSDirector/PDMR Shareholding
12th Jul 20217:00 amRNSTR1 Notification
25th Jun 202112:43 pmRNSResult of AGM
25th Jun 20217:00 amRNSAGM Statement
23rd Jun 20211:15 pmRNSAGM Notice
22nd Jun 20217:00 amRNSProject WAVE recruits first patient
16th Jun 20219:18 amRNSDirector/PDMR Shareholding
16th Jun 20217:00 amRNSCapital Markets Day
28th May 20217:00 amRNSAnnual Report 2021 and Notice of AGM
20th May 20212:15 pmRNSMello Healthcare Presentation 25th May 2021
17th May 20217:00 amRNS£1.25m Ventilator Order received from China
29th Apr 20217:00 amRNSQueen’s Award for Enterprise for SLE Ltd
29th Apr 20217:00 amRNSTR1 Notification
27th Apr 20217:00 amRNSFinal Results
21st Apr 20217:00 amRNSSLE 6000 & OxyGenie® China approval &250k Order
19th Apr 20215:30 pmRNSTR1 Notification
19th Apr 20215:30 pmRNSTR1 Notification
19th Apr 20215:30 pmRNSTR1 Notification
29th Mar 20217:00 amRNSDistribution Agreement and MoU
16th Mar 20217:00 amRNSSLE 6000 & OxyGenie® Japan approval & £400k Order
23rd Feb 20212:10 pmRNSSecond Price Monitoring Extn
23rd Feb 20212:01 pmRNSPrice Monitoring Extension
23rd Feb 202111:06 amRNSSecond Price Monitoring Extn
23rd Feb 202111:01 amRNSPrice Monitoring Extension
18th Feb 20217:00 amRNSResults date and post period end update
15th Feb 20214:41 pmRNSSecond Price Monitoring Extn
15th Feb 20214:36 pmRNSPrice Monitoring Extension
15th Feb 20212:06 pmRNSSecond Price Monitoring Extn
15th Feb 20212:00 pmRNSPrice Monitoring Extension
15th Feb 202111:06 amRNSSecond Price Monitoring Extn
15th Feb 202111:01 amRNSPrice Monitoring Extension
15th Feb 20219:06 amRNSSecond Price Monitoring Extn
15th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20212:06 pmRNSSecond Price Monitoring Extn
11th Feb 20212:01 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSRevenue and Profit Upgrade
21st Jan 20217:00 amRNSExercise of options and Total Voting Rights
14th Jan 20217:00 amRNSTR1 Notification
2nd Dec 20207:00 amRNSEuropean Patent granted for Project WAVE
1st Dec 20201:16 pmRNSInspiration wins AIM Transaction of the Year Award
16th Nov 20207:00 amRNSProject WAVE MHRA Approval
29th Oct 20207:00 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.